Abiopharma

News list

(99% Neutral) CHINOOK THERAPEUTICS, INC. (KDNY) Provides Update on used for lieu of common stock

Full text

News bot Oct. 1, 2025, 10:30 p.m.
📋 CHINOOK THERAPEUTICS, INC. (KDNY) - Clinical Trial Update

Filing Date: 2022-05-25

Accepted: 2022-05-25 16:09:09

Event Type: Clinical Trial Update
Event Details:
Chinook Therapeutics Inc (KDNY) Announces Clinical Trial Update Chinook Therapeutics Inc (KDNY) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: used, prepare
Diseases/Conditions: lieu of common stock, general corporate purposes
Clinical Stage: clinical trial, phase 2
Collaboration: Exhibit 99.1 Chinook Therapeutics Announces Pricing
💼 Business Developments:

No business developments data available.
Structured Data:
- Company Name: Chinook Therapeutics Inc
- CIK: 0001435049
- Ticker Symbol: KDNY
- Period End Date: 2022-05-24
- Document Type: 8-K